Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIBOFLAVIN 5'-PHOSPHATE: 249 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
249
Total FAERS Reports
0
Deaths Reported
3
Hospitalizations
249
As Primary/Secondary Suspect
3
Disabilities
Apr 15, 2016
FDA Approved
Prescription
Status

Active Ingredient: RIBOFLAVIN 5'-PHOSPHATE SODIUM · FDA Application: 203324 ·

First Report: 2015 · Latest Report: 20210423

What Are the Most Common RIBOFLAVIN 5'-PHOSPHATE Side Effects?

#1 Most Reported
Eye pain
60 reports (24.1%)
#2 Most Reported
No adverse event
48 reports (19.3%)
#3 Most Reported
Therapy cessation
42 reports (16.9%)

All RIBOFLAVIN 5'-PHOSPHATE Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Eye pain 60 24.1% 0 0
No adverse event 48 19.3% 0 0
Therapy cessation 42 16.9% 0 0
Corneal opacity 38 15.3% 0 0
Corneal epithelium defect 29 11.7% 0 0
Visual impairment 25 10.0% 0 0
Photophobia 21 8.4% 0 0
Ocular discomfort 20 8.0% 0 0
Vision blurred 19 7.6% 0 0
Inappropriate schedule of drug administration 17 6.8% 0 0
Product use issue 17 6.8% 0 0
Corneal infiltrates 15 6.0% 0 0
Corneal scar 15 6.0% 0 0
Corneal thinning 15 6.0% 0 0
Ulcerative keratitis 15 6.0% 0 0
Keratitis 12 4.8% 0 0
Corneal oedema 9 3.6% 0 0
Inappropriate schedule of product administration 9 3.6% 0 0
Incorrect product administration duration 7 2.8% 0 0
Discomfort 6 2.4% 0 0

Who Reports RIBOFLAVIN 5'-PHOSPHATE Side Effects? Age & Gender Data

Gender: 31.4% female, 68.6% male. Average age: 31.1 years. Most reports from: US. View detailed demographics →

Is RIBOFLAVIN 5'-PHOSPHATE Getting Safer? Reports by Year

YearReportsDeathsHosp.
2015 2 0 0
2016 20 0 0
2017 37 0 0
2018 49 0 2
2019 51 0 0
2020 16 0 0
2021 10 0 0

View full timeline →

What Is RIBOFLAVIN 5'-PHOSPHATE Used For?

IndicationReports
Keratoconus 164
Product used for unknown indication 76
Corneal disorder 6

RIBOFLAVIN 5'-PHOSPHATE vs Alternatives: Which Is Safer?

RIBOFLAVIN 5'-PHOSPHATE vs RIBOFLAVIN 5^-PHOSPHATE RIBOFLAVIN 5'-PHOSPHATE vs RIFABUTIN RIBOFLAVIN 5'-PHOSPHATE vs RIFAMPICIN RIBOFLAVIN 5'-PHOSPHATE vs RIFAMPIN RIBOFLAVIN 5'-PHOSPHATE vs RIFAMYCIN RIBOFLAVIN 5'-PHOSPHATE vs RIFAPENTINE RIBOFLAVIN 5'-PHOSPHATE vs RIFAXIMIN RIBOFLAVIN 5'-PHOSPHATE vs RILMENIDINE RIBOFLAVIN 5'-PHOSPHATE vs RILONACEPT RIBOFLAVIN 5'-PHOSPHATE vs RILPIVIRINE

Official FDA Label for RIBOFLAVIN 5'-PHOSPHATE

Official prescribing information from the FDA-approved drug label.